We have very few HBeAg positive patients here in Europe.
在欧洲，我们e抗原阳性的患者很少。
Early research has shown that a 48-week course of adefovir provides clinical improvements in patients with HBeAg-negative chronic hepatitis B.
早期的研究已经显示，对慢性乙型肝炎e抗原阴性的患者进行48周阿德福韦治疗后，获得了临床上的改善。
Current antiviral treatment can successfully control the HBV replication, and can induce HBeAg seroconversion in some patients with chronic HBV infection.
目前的抗病毒治疗可以成功控制HBV的复制，能够诱导一些慢性HBV感染患者出现血清转换。
Methods the serum YMDD mutation, HBV DNA, ALT and HbeAg levels of 60 patients on lamivudine therapy were detected by FQ-PCR, ELISA, and rate method, respectively.
方法采用实时荧光定量pcr、ELISA及速率法分别检测60例乙肝患者经拉米呋啶治疗后其血清YMDD、HBVDNA、乙肝标志物及alt的变化情况。
Methods This study included 46 CHB patients and 17 hepatic cirrhosis patients and they were divided into two groups according to HBeAg positive and HBeAg negative.
方法 经血清学及肝穿刺病理组织学证实为CHB46例，经血清学及影像学确诊、手术获得的肝硬化标本17例。
Methods This study included 46 CHB patients and 17 hepatic cirrhosis patients and they were divided into two groups according to HBeAg positive and HBeAg negative.
方法 经血清学及肝穿刺病理组织学证实为CHB46例，经血清学及影像学确诊、手术获得的肝硬化标本17例。
应用推荐